BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/03/1994

Opportunity for a License: Identification of a Suppressor of Atherogenic Apolipoprotein

The National Institutes of Health is seeking a licensee for a new invention that identifies a genetic sequence suppressing apolipoprotein B transcription, which is linked to cardiovascular disease.

Source: Federal Register — Health and Human ServicesOpen original release →